New Tools for Molecular Therapy of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, arising from neoplastic transformation of hepatocytes or liver precursor/stem cells. HCC is often associated with pre-existing chronic liver pathologies of different origin (mainly subsequent to HBV and HCV infections), such as...
Main Authors: | Alessandra Marchetti, Francesca Bisceglia, Angela M. Cozzolino, Marco Tripodi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-10-01
|
Series: | Diseases |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-9721/3/4/325 |
Similar Items
-
TGFβ Impairs HNF1α Functional Activity in Epithelial-to-Mesenchymal Transition Interfering With the Recruitment of CBP/p300 Acetyltransferases
by: Francesca Bisceglia, et al.
Published: (2019-08-01) -
miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling
by: Dong-Min Shi, et al.
Published: (2018-11-01) -
The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment
by: Marco D'Anzeo, et al.
Published: (2014-05-01) -
Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma
by: Athanasios Armakolas, et al.
Published: (2022-10-01) -
Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression
by: Wenwen Sun, et al.
Published: (2015-12-01)